Literature DB >> 19842798

Spontaneous increases in impedance following cochlear implantation: suspected causes and management.

J Neuburger1, T Lenarz, A Lesinski-Schiedat, A Büchner.   

Abstract

Modern cochlear implant systems deliver impulse transmission rates up to 50,000 pps. It emerged that the fast stimulation rates led to enhanced speech comprehension. Impedance measurement is an important aspect in cochlear implant testing procedures. Impedance values are a measure of the electrical resistance between the individual implant electrodes. Increased impedances were attributed frequently to inflammatory/tissue-related processes. In recent years, however, we have repeatedly found cases of impedance increase for which the inflammatory model did not provide a satisfactory explanation. The aim of this study is to evaluate increases in impedance in our cochlear implant population, to attempt to find their cause, and to formulate therapeutic hypotheses. In our cochlear implant programme (> 3000 recipients) we screened our database for impedance increases over time during device fitting. We found 16 patients with 18 affected ears in whom impedance increases were clearly demonstrated. We found that especially in cases without any sign of prior inflammation, increasing the pulse width of the stimulation strategy seems to be an effective tool to return increased impedances to normal levels.

Entities:  

Mesh:

Year:  2009        PMID: 19842798     DOI: 10.1080/14992020802600808

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  8 in total

1.  Programming peculiarities in two cochlear implant users with superficial siderosis of the central nervous system.

Authors:  Aline Gomes Bittencourt; Maria Valéria Schmidt Goffi-Gomez; Mariana Hausen Pinna; Ricardo Ferreira Bento; Rubens de Brito; Robinson Koji Tsuji
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-26       Impact factor: 2.503

2.  Systemic immunity influences hearing preservation in cochlear implantation.

Authors:  Melanie Souter; Hayden Eastwood; Paul Marovic; Gordana Kel; Sarin Wongprasartsuk; Allen F Ryan; Stephen John O'Leary
Journal:  Otol Neurotol       Date:  2012-06       Impact factor: 2.311

3.  Middle Ear Disease and Cochlear Implant Function: A Case Study.

Authors:  Joshua F Dixon; Jennifer B Shinn; Meg Adkins; Bryan D Hardin; Matthew L Bush
Journal:  Hearing Balance Commun       Date:  2014-06-11

4.  Delayed changes in auditory status in cochlear implant users with preserved acoustic hearing.

Authors:  Rachel A Scheperle; Viral D Tejani; Julia K Omtvedt; Carolyn J Brown; Paul J Abbas; Marlan R Hansen; Bruce J Gantz; Jacob J Oleson; Marie V Ozanne
Journal:  Hear Res       Date:  2017-04-12       Impact factor: 3.208

5.  Long-Term Surface Electrode Impedance Recordings Associated with Gliosis for a Closed-Loop Neurostimulation Device.

Authors:  Karl A Sillay; Solomon Ondoma; Brett Wingeier; Dominic Schomberg; Priyanka Sharma; Rahul Kumar; Gurwattan S Miranpuri; Justin Williams
Journal:  Ann Neurosci       Date:  2019-01-14

6.  Exploiting Routine Clinical Measures to Inform Strategies for Better Hearing Performance in Cochlear Implant Users.

Authors:  Alan P Sanderson; Edward T F Rogers; Carl A Verschuur; Tracey A Newman
Journal:  Front Neurosci       Date:  2019-01-15       Impact factor: 4.677

7.  First-in-human intracochlear application of human stromal cell-derived extracellular vesicles.

Authors:  Athanasia Warnecke; Nils Prenzler; Jennifer Harre; Ulrike Köhl; Lutz Gärtner; Thomas Lenarz; Sandra Laner-Plamberger; Georg Wietzorrek; Hinrich Staecker; Teresa Lassacher; Julia Hollerweger; Mario Gimona; Eva Rohde
Journal:  J Extracell Vesicles       Date:  2021-06-04

8.  Platinum corrosion products from electrode contacts of human cochlear implants induce cell death in cell culture models.

Authors:  Kirsten Wissel; Gudrun Brandes; Nils Pütz; Gian Luigi Angrisani; Jan Thieleke; Thomas Lenarz; Martin Durisin
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.